Loading…
Citizens Financial Group, Inc.
NYSE: CFG Financials Bank 🔎 Screen
S&P 500
🏹 Trader: 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High | BRS 69 Forming View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$30.5B
Market Cap
15.1
P/E
0.48
PEG
ROCE
7.2%
ROE
0.50
D/E
OPM
-5.7%
% from 52W High
76
α RS
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for CFG including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Citizens Financial Group, Inc. operates as the bank holding company that provides retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions in the United States. The company operates through two segments, Consumer Banking and Commercial Banking. The Consumer Banking segment offers deposit products, mortgage and home equity lending products, credit cards, business loans, and wealth management services; and education and point-of-sale finance loans, as well as digital deposit products. This segment serves its customers through telephone service centers, as well as through its online and mobile platforms. The Commercial Banking segment provides various financial products and solutions, including lending and leasing, deposit and treasury management services, foreign exchange, and interest rate and commodity risk management solutions, as well as syndicated loans, corporate finance, mergers and acquisitions, and debt and equity capital markets services. The company serves customers and small businesses, high- and ultra-high-net-worth individuals and families, as well as investors, entrepreneurs, and companies and institutions, as well as multifamily, office, industrial, retail, healthcare, and hospitality sectors. The company was formerly known as RBS Citizens Financial Group, Inc. and changed its name to Citizens Financial Group, Inc. in April 2014. Citizens Financial Group, Inc. was founded in 1828 and is headquartered in Providence, Rhode Island.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding CFG
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 1.81M $108.8M 0.14% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 5 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q2 2026
Revenue
$2.3B
+12% YoY
Operating Income
$889M
+24% YoY
Operating Margin
38.9%
+3.7pp YoY
Net Income
$587M
+35% YoY
What Went Right
  • NII up 4.4% QoQ and 14% YoY, with NIM up 3bps QoQ to 3.17%.
  • Record second-quarter capital markets fees, up 14% QoQ and 46% YoY; wealth fees hit an all-time high, up 16% YoY.
  • Credit improved: net charge-offs fell to 37bps, nonaccrual loans down 4% QoQ, and DFAST stress loss ranked third best among regional peers.
What to Watch
  • CET1 dipped to 10.4%, below the 10.5% target, due to stronger-than-expected loan growth.
  • Deposit costs ticked up 3-4bps and FHLB funding increased to support the loan growth.
  • Some CRE paydowns slipped into Q3, and the non-core auto portfolio continued to run off by roughly $400M in the quarter.
Management Guidance
  • Q3 2026: NII up 2.5%-3.5%, noninterest income up ~1%, expenses stable to up slightly, NCOs stable to down slightly.
  • Q3 2026 CET1 expected at ~10.5% with ~$125M of share repurchases.
  • Full-year revenue trending above initial January guidance, with >600bps of positive operating leverage expected for 2026.
  • NIM guidance: 3.22%-3.27% by the end of 2026 and 3.30%-3.50% in 2027; 16%-18% ROTCE target by end-2027.
Investor Lens
The thesis is stronger after this call. Revenue momentum is broad-based, with NII, capital markets, wealth, and the private bank all contributing, while credit trends remain favorable. The only notable blemish is CET1 slipping slightly below target due to accelerat­ed loan growth, but management expects to rebuild to ~10.5% next quarter. The path to 16%-18% ROTCE now looks more tangible with NIM expansion, private bank scaling, and continued positive operating leverage.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Strong quarter: EPS $1.30, revenue up 12% YoY.
Revenue
Total revenue was $2.28B, up 12% YoY, driven by NII up 14% and fees up 9% YoY. Capital markets posted a record Q2, up 46% YoY, and wealth fees reached an all-time high.
Profitability
Net income rose 35% YoY to $587M, with diluted EPS of $1.30, up 41% YoY. Pre-provision profit increased 24% YoY to $889M, while ROTCE improved to 13.9% from 11.0% a year ago.
Margins
Efficiency ratio improved to 61.1% from 64.8% in the prior year, driving 6.4% positive operating leverage YoY. NIM expanded 22bps YoY to 3.17%, with sequential strength supported by fixed asset repricing and swap benefits.
Balance Sheet
Period-end loans grew 3% QoQ to $147.5B, and average deposits were up 1% QoQ to $183.6B. The CET1 ratio was 10.4%, down slightly below the 10.5% target, with $225M of buybacks executed in the quarter.
Key Risks
Management flagged deposit competition pressuring funding costs, and some CRE paydowns were delayed into Q3. Elevated geopolitical uncertainty and the possibility of Fed rate hikes were also noted as potential headwinds.
Outlook
For Q3, Citizens expects NII up 2.5%-3.5%, fees up ~1%, and expenses stable to up slightly. Full-year revenue is tracking above initial guidance, with >600bps of positive operating leverage targeted for 2026.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-16
Q2 2026 saw record revenue, 15% sequential and 41% year-over-year EPS growth, and ROTCE at 13.9%. NII and fee income rose sharply, with strong loan and deposit growth across all segments. Guidance points to continued NIM expansion, robust capital, and a clear path to 16%-18% ROTCE by 2027.
Q1 2026 Q1 2026 2026-04-16
Q1 2026 saw 47% EPS growth, strong NIM expansion, and record capital markets fees. Private bank and wealth segments drove profitability, while strategic initiatives and disciplined capital allocation support a positive outlook for 2026 and beyond.
Q4 2025 Q4 2025 2026-01-21
Strong Q4 and full-year 2025 results featured robust EPS growth, margin expansion, and record wealth and capital markets performance. 2026 guidance calls for double-digit NII growth, continued positive operating leverage, and significant investments in technology and the Private Bank.
Q3 2025 Q3 2025 2025-10-15
Third-quarter results showed strong EPS and NII growth, record capital markets and wealth performance, and robust private bank expansion. Guidance calls for continued positive operating leverage, stable credit, and further capital returns, with strategic initiatives set to drive future gains.
Q2 2025 Q2 2025 2025-07-17
Q2 2025 results exceeded expectations with strong NII, fee growth, and positive operating leverage. All segments saw loan growth, credit trends improved, and strategic initiatives advanced, including a major AI-driven transformation. CET1 remained robust, and guidance for continued growth and profitability was reaffirmed.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.